NCT01014546 2022-07-22
Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis
Roswell Park Cancer Institute
Phase 1 Terminated
Clinical Trials
6 trialsNCT00234000 2020-07-31
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT00571116 2019-08-07
Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy
University of California, Irvine
Phase 1 Terminated
NCT01397734 2018-09-06
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT00590603 2014-01-08
AAV
Duke University
Phase 1 Terminated
NCT00985530 2013-10-30
Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia
Northwestern University
Phase 1 Terminated